Qualified academic and industrial laboratories seeking to place a high-purity GHRP-2 order require rigorous analytical verification, lot-to-lot consistency, and rapid supply chain dispatch. PX1 Research supplies USA-manufactured, research-grade GHRP-2 (Growth Hormone Releasing Peptide 2) validated via RP-HPLC, mass spectrometry, and endotoxin assays. All compounds are distributed strictly for in vitro experimentation and preclinical secretagogue research.
Qualified academic and industrial laboratories seeking to place a high-purity GHRP-2 order require rigorous analytical verification, lot-to-lot consistency, and rapid supply chain dispatch. PX1 Research supplies USA-manufactured, research-grade GHRP-2 (Growth Hormone Releasing Peptide 2) validated via RP-HPLC, mass spectrometry, and endotoxin assays. All compounds are distributed strictly for in vitro experimentation and preclinical secretagogue research.
To place a verified GHRP-2 order for laboratory research, institutional buyers must select ISO 17025-accredited chemical suppliers offering analytical validation for every lot. Pure GHRP-2 (D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2) should be sourced as a lyophilized trifluoroacetate salt exhibiting greater than 98% purity, accompanied by lot-specific RP-HPLC chromatograms, mass spectrometry profiles, and low-endotoxin assay certificates.
Securing high-purity reagents is essential for eliminating confounding variables in cell culture assays and animal model trials. When researchers order through the PX1 Research catalog, each batch undergoes stringent quality control in USA-based, GMP-compliant facilities. Orders placed prior to daily cutoffs ship same-day from distribution nodes in California and Arizona, ensuring minimal transit degradation and total lot-to-lot consistency.
GHRP-2, chemically designated as Growth Hormone Releasing Peptide 2 or Pralmorelin, is a synthetic hexapeptide belonging to the growth hormone secretagogue (GHS) class. Its primary sequence—D-Ala-D-β-Nal-Ala-Trp-D-Phe-Lys-NH2—incorporates unnatural D-amino acids designed to confer enhanced enzymatic stability against native systemic endopeptidases compared to endogenous peptides.
With a molecular formula of C45H55N9O6 and a molecular weight of approximately 818.0 g/mol, GHRP-2 functions as a potent agonist of the growth hormone secretagogue receptor 1a (GHS-R1a). Unlike native hypothalamic growth hormone-releasing hormone (GHRH), which binds to the GHRH receptor, GHRP-2 utilizes the ghrelin receptor pathway to induce intracellular signaling cascades. Understanding this structural configuration allows investigators to model receptor kinetics and ligand-binding affinities in recombinant tissue systems.
The primary mechanism of GHRP-2 centers on its high-affinity interaction with the GHS-R1a receptor, a G-protein-coupled receptor (GPCR) expressed predominantly in anterior pituitary somatotrophs and hypothalamic neurons. Upon ligand binding, GHS-R1a activates the phospholipase C (PLC) signal transduction pathway, leading to the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) into inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG).
The generation of IP3 triggers the immediate release of stored intracellular calcium ions (Ca2+) from the endoplasmic reticulum into the cytoplasm. This transient surge in free intracellular calcium, combined with DAG-mediated protein kinase C (PKC) activation, stimulates the exocytosis of pre-stored growth hormone granules. Preclinical research demonstrates that this pathway operates synergistically with endogenous GHRH signaling, providing a dual-stimulatory model for evaluating somatotroph responsiveness in vitro.
Extensive in vitro assays and animal model studies have evaluated GHRP-2 to map secretagogue pharmacology and neuroendocrine dynamics. In primary pituitary cell cultures, exposure to nanomolar concentrations of GHRP-2 induces rapid, concentration-dependent growth hormone secretion. These studies confirm that GHRP-2 exhibits significantly higher intrinsic activity than first-generation secretagogues like GHRP-6 while maintaining selective receptor engagement.
In rodent models, research indicates that systemic or central administration of GHRP-2 stimulates food intake and alters energy homeostasis in addition to releasing somatotropin. This secondary orexigenic effect occurs because GHS-R1a receptors are heavily expressed in the arcuate nucleus of the hypothalamus, particularly on neuropeptide Y (NPY) and agouti-related protein (AgRP) neurons. Investigators utilizing GHRP-2 in metabolic research models frequently quantify these central signaling pathways to study satiety regulation and ghrelin-mimetic pharmacology.
When designing comparative secretagogue protocols, researchers frequently evaluate GHRP-2 alongside related synthetic ligands within the same class. Understanding the subtle differences in receptor selectivity, downstream signaling, and secondary endocrine activation is vital for selecting the appropriate peptide for specific assay parameters.
For instance, while GHRP-6 shares a similar hexapeptide backbone, preclinical assays indicate that GHRP-2 possesses greater binding potency at GHS-R1a, producing a more pronounced release of somatotropin per molar concentration. Conversely, selective agonists like Ipamorelin exhibit minimal impact on secondary pituitary axes (such as adrenocorticotropic hormone or prolactin), whereas GHRP-2 may induce modest elevation of ACTH and cortisol in certain animal models. For broader comparative research into growth factor pathways, investigators often contrast these GHS-R1a agonists against GHRH analogues like CJC-1295 or examine systemic downstream effects using IGF-1 LR3. Explore our comprehensive secretagogue signaling research guides for detailed cross-compound data.
In modern biochemical research, the integrity of synthetic peptides directly dictates experimental reproducibility. Impurities such as truncated peptide sequences, deletion sequences, or residual TFA can alter binding kinetics and yield false positives in receptor assays. Consequently, ordering GHRP-2 requires absolute verification of chemical purity through complementary analytical techniques.
Every batch of GHRP-2 research peptide supplied by PX1 Research undergoes strict analytical evaluation. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) is utilized to confirm chemical purity exceeds 98%, mapping retention times against reference standards to ensure the absence of closely related synthetic artifacts. Concurrently, Electrospray Ionization Mass Spectrometry (ESI-MS) confirms exact molecular weight (818.0 g/mol), verifying sequence fidelity. Certificates of Analysis (COAs) detailing lot-specific HPLC and MS spectra are publicly available for every production run.
For cell culture assays, primary tissue cultures, and sensitive in vivo animal models, bacterial endotoxin contamination poses a critical threat to research integrity. Lipopolysaccharides (LPS) derived from Gram-negative bacterial outer membranes can activate Toll-like receptor 4 (TLR4), triggering inflammatory cytokine cascades that obscure experimental endpoints.
To protect research validity, PX1 Research implements rigorous Limulus Amebocyte Lysate (LAL) testing on all lot batches. Endotoxin levels are quantified and certified to remain well below established thresholds (<0.01 EU/μg peptide). Combined with sterile filtration and synthesis in ISO 7 cleanroom environments, this stringent testing ensures that reagents do not introduce unwanted immunological background signals into preclinical experimental setups.
Lyophilized GHRP-2 is supplied as a stable, sterile powder. Upon receipt, the sealed vial should be stored in a climate-controlled freezer at -20°C (or -80°C for long-term storage), protected from light and ambient moisture. Under these conditions, the un-reconstituted peptide maintains stability for up to 24 months.
For laboratory reconstitution, researchers should allow the vial to equilibrate to room temperature before adding a suitable solvent, such as sterile bacteriostatic water or laboratory-grade phosphate-buffered saline (PBS). Gentle rotation of the vial is recommended to achieve complete dissolution; violent agitation or vortexing should be avoided as mechanical shear stress can denature delicate peptide bonds. Once reconstituted, liquid aliquots should be stored at 2°C to 8°C and utilized within 14 to 21 days, or flash-frozen in single-use working volumes to prevent repeated freeze-thaw degradation cycles.
Supply chain interruptions and variable international reagent quality can severely impede laboratory research schedules. Sourcing synthetic peptides manufactured within domestic, GMP-compliant facilities guarantees consistent quality standards and rapid fulfillment.
PX1 Research operates dual fulfillment centers situated in California and Arizona to support domestic academic, biotech, and institutional facilities. Placing a GHRP-2 order prior to cut-off times guarantees same-day processing (Monday through Friday), utilizing temperature-monitored packaging protocols. This robust logistics structure mitigates environmental exposure during transit, ensuring reagents arrive at your facility with structural integrity fully intact.
High-throughput screening platforms and longitudinal preclinical studies demand large-scale peptide batches with uniform physical characteristics. Batch-to-batch variation can introduce drift into longitudinal datasets, necessitating consistent lot reservation for extended research projects.
Principal investigators and procurement officers requiring multi-gram quantities or dedicated lot allocation can utilize our specialized wholesale lab account portal. PX1 Research offers custom vial sizing, specialized bulk packaging, and reserved lot inventory services to support long-term laboratory contracts. Institutional procurement teams receive dedicated technical support and immediate access to complete analytical documentation for compliance audit trails.
What is the certified chemical purity of PX1 Research GHRP-2?
Every lot of GHRP-2 supplied by PX1 Research is certified to meet or exceed 98% purity as measured by Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and verified via Electrospray Ionization Mass Spectrometry (ESI-MS).
How is GHRP-2 shipped to prevent thermal degradation during transit?
Lyophilized GHRP-2 is stable at ambient temperatures during short transit windows. Orders ship same-day (Monday through Friday) from our California or Arizona hubs using rapid domestic carriers. For extreme climate conditions, cold-pack insulation is utilized.
What solvent is recommended for reconstituting GHRP-2 for in vitro research?
For standard laboratory applications, reconstituting with sterile bacteriostatic water or sterile standard saline (0.9% NaCl) is recommended. For specific cell culture assays requiring neutral pH balance, sterile phosphate-buffered saline (PBS) may be utilized.
What are the endotoxin limits for PX1 Research GHRP-2 lots?
All peptide lots undergo rigorous LAL (Limulus Amebocyte Lysate) assay testing to verify that bacterial endotoxin levels remain below standard analytical thresholds (<0.01 EU/μg), making them suitable for sensitive preclinical research.
How should reconstituted GHRP-2 solutions be stored in the lab?
Reconstituted GHRP-2 solutions should be stored in liquid form at 2°C to 8°C for short-term evaluation (up to 3 weeks). For long-term storage, solutions should be divided into single-use aliquots and frozen at -20°C or -80°C to avoid repeated freeze-thaw cycles.
What primary receptor target is evaluated in GHRP-2 research?
GHRP-2 acts as a potent agonist at the Growth Hormone Secretagogue Receptor 1a (GHS-R1a), a G-protein-coupled receptor located primarily on anterior pituitary somatotrophs and hypothalamic neurons.
How does GHRP-2 differ from GHRP-6 in preclinical studies?
In preclinical binding assays, GHRP-2 generally demonstrates higher potency at the GHS-R1a receptor than GHRP-6, resulting in stronger somatotroph calcium influx per nanomolar concentration, while both exhibit ghrelin-mimetic orexigenic properties.
Can institutional buyers obtain bulk or reserved-lot allocations of GHRP-2?
Yes. Institutional researchers and laboratory procurement teams can set up wholesale accounts through PX1 Research to secure bulk quantities, custom vial configurations, and single-lot reservation services for longitudinal studies.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.